Drug reference
doxylamine succinate
Histamine H1 antagonist · Antiemetic
Histamine H1 antagonistAntiemeticATC R06AA09
CDSCO approvedATC R06AA09
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Doxylamine succinate is a histamine H1 antagonist. When combined with pyridoxine, it effectively treats mild-to-moderate nausea and vomiting of pregnancy. Its exact antiemetic mechanism for pregnancy is not fully elucidated but involves antihistaminic properties.
Indications
Nausea and vomiting of pregnancy
Dosing
- Adult
- Initially, two delayed-release tablets (doxylamine 20 mg, pyridoxine 20 mg) at bedtime. May be increased to four tablets per day as needed (one morning, one afternoon, two bedtime).
Pharmacokinetics
Half-life
10 to 12 h
Metabolism
N-dealkylation in the liver
Excretion
In the urine
Side effects
Common
DrowsinessDry mouthLight-headednessConstipation
Related guidelines
Iron deficiency anaemia in pregnancy
ICMR · Obstetrics & Gynaecology · 2022
Hypertensive disorders of pregnancy
FOGSI · Obstetrics & Gynaecology · 2019
Iron deficiency anaemia in pregnancy
FOGSI · Obstetrics & Gynaecology · 2017
Multifetal pregnancy
FOGSI · Obstetrics & Gynaecology · 2024
Hypertensive disorders of pregnancy
ACOG · Obstetrics & Gynaecology · 2020
Ask House about doxylamine succinate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team